PCV90 The Quality of Anticoagulation Therapy in Patients with Atrial Fibrillation  by Wilke, T. & Müller, S.
ponent score (MCS). Linear regression analysis was conducted with PCS and MCS
scores as dependent variables. Age, race and sex were included as baseline vari-
ables in all models while incorporating Charlson/D’hoore, Elixhauser, and HRQoL-
CI measures one at a time. Adjusted R2 were compared to assess the comparative
performances of risk-adjustment measures. RESULTS: The mean age was 6813
years, with 80.63% non-Hispanic whites. The average PCS and MCS for HF patients
were 45.5312.28 and 30.6411, respectively. HRQoL-CI (R2 0.2083) outperformed
Elixhauser (R2  0.1784) and Charlson/D’hoore (R2  0.1359) in predicting PCS.
Whereas, Elixhauser (R2  0.2184) had the best prediction of MCS compared to
HRQoL-CI (R2  0.1920) and Charlson/D’hoore (R2  0.0918). CONCLUSIONS: No
single comorbidity measure was best in predicting both PCS and MCS in HF pa-
tients; HRQoL-CI performed best in predicting PCS whereas Elixhauser measure
had the best prediction for MCS. Selection of risk adjustment method should be
based on the type of dimension used to evaluate HRQoL.
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OBJECTIVES: Re-hospitalization in heart failure (HF) patients is often the result of a
patient’s inability to adequately self-manage the condition. The objective of this
study is to determine if engaging inpatients in their care through technology is a
solution to improving patient self-management. METHODS: Two hundred seven-
ty-five patients with HF completed the HF interactive care plan while an inpatient
at one of six hospitals throughout the United States. A pretest posttest design was
used to evaluate a patient’s activation using the 13-item Patient Activation Mea-
sure (PAM-13), a valid and reliable instrument to measure a patient’s knowledge,
skill, and confidence to perform self-management of their chronic disease(s). After
completing the baseline PAM-13 following admission for a HF diagnosis, all 275
patients completed a self-paced set of interactive, educational modules through-
out their inpatient stay. These modules were typically completed 3 or 4 days after
admission, and then patients would complete the PAM-13 prior to discharge. The
PAM-13 places individuals into activation levels 1 (lowest) through 4 (highest)
based on an individual’s responses. RESULTS:A two-tailed t-test between baseline
and posttest scores of all participants showed a difference of 0.38 levels of activa-
tion (p .001). Because 168 of the 275 participants were at level 4 on the PAM-13 at
baseline, these individuals were removed and secondary analysis was performed
on the remaining 107 individuals. A two-tailed t-test revealed a difference of 1.05
levels of activation (p 0.001) after patients completed the interactive solution.
CONCLUSIONS: Providing education through an interactive solution while in the
hospital can improve activation scores in HF patients.
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OBJECTIVES: To determine blood pressure goal attainment levels and the factors
influencing them for a low-income, uninsured population with hypertension.
METHODS: A retrospective, cohort study was carried out by reviewing patient
charts at three different sites where patients from CareNet, a Toledo based safety-
net organization, received primary care. Eligible subjects were at least 18 years old
andwere CareNetmembers for aminimumduration of one year between the study
period of January 1, 2003 to December 31, 2008. Descriptive statistics were utilized
to determine goal attainment. Chi-square analysiswas used to determine variables
that had significantly different goal attainment. A binomial logistic regression
model was used to predict goal attainment. Goal attainment at the last recorded
visit served as the dependent variable and was classified as ‘Yes’ and ‘No’ (deter-
mined based on JNC-VII guidelines). Age, gender, race/ethnicity, BMI, tobacco use,
number of primary care visits, and pharmacotherapy treatment were used as pre-
dictor variables. RESULTS: A total of 269 patients were included in the final analy-
sis; 92 of these patients had diabetes while 177 didn’t have diabetes as co-morbid-
ity. The overall goal attainment was found to be 42.39% (n39) in the patients with
diabetes as co-morbidity and 60.45% (n107) among thememberswithout diabetes
as co-morbidity. Chi-square analysis found patients the variables of co-morbidity
(p0.05) and number of visits (p0.01) had significant differences in goal attain-
ment. Patients who had primary care visits between 6-10 times were found to be
significantly more likely (OR3.705; CI: 1.670-8.218) to attain goal when compared
to those who had just 1-5 visits. Notable trends were observed for other variables
(co-morbidity,race/ethnicity,tobacco) but the effect was not significant.
CONCLUSIONS: Goal attainment among CareNet members was found to be com-
parable to other studies and national statistics. Encouraging regular utilization of
primary care services may further improve the clinical outcomes for a population
utilizating a safety-net organization.
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OBJECTIVES: The role of patient- and hospital-level factors in predicting hospital
readmissions in the cardiovascular disease (CVD) setting is established, while the
contribution of community-level factors is less clear. We determine the contribu-
tion of county-level characteristics in predicting discharge and readmission
outcomes. METHODS: This retrospective analysis of hospital discharge data in-
cluded adult patients discharged alive from nonfederal acute care hospitals be-
tween 2000 and 2005. Merged hospital- and county- level data characterized the
admitting hospital in terms of quality of care and the patients’ residence county in
terms of income, crime, medical social services, and private transportation. Multi-
nomial logistic and logistic regression models examined, respectively, the likeli-
hood of 1) 3 discharge outcomes (home, unauthorized discharge, or furthermedical
care), and 2) 31-day same-hospital readmission. The likelihood ratio (LR) test and
Akaike Information Criterion (AIC) compared 3 models: Model 1: patient-level,
Model 2: patient- and hospital-level, and Model 3: patient-, hospital- and
county-level. RESULTS: Application of inclusion criteria resulted in 348,572 dis-
charges with a primary-listed discharge diagnosis of CVD. In the discharge out-
comes models, results from the LR tests that compared Model 2 to Model 1, and
Model 3 to Model 2 were statistically significant (2  773.38, p0.0001; 2 
1346.80, p0.0001), suggesting no data support for the implied restrictions in Mod-
els 1 and 2. The AIC forModels 1, 2, and 3were 309139, 308378, and 307047, favoring
Model 3. In the 31-day readmissionmodels, results from the LR tests that compared
Model 2 to Model 1, and Model 3 to Model 2 also were statistically significant (2 
34.73, p0.0001; 2  89.62, p0.0001). The AIC for Models 1, 2, and 3 were 144041,
144012, and 143931. CONCLUSIONS: Prediction models examining discharge and
readmissions outcomes can benefit from the inclusion of patient-, hospital, and
area (e.g. county) – level measures.
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OBJECTIVES: The aim of this research was to assess the quality of anticoagulation
therapy of patients with atrial fibrillation (AF) in a real life setting and to identify
the causal factors explaining anticoagulation quality deficits. Furthermore, clinical
consequences of suboptimal anticoagulation therapy (strokes, TIA, bleedings, em-
bolism, myocardial infarcts) are identified. METHODS: The INR values as well as
other clinical events concerning AF patients recruited into a prospective cohort
study (observation period of 12 month) were documented at every visit to the
treating doctor. Using the Rosendaal linear trend method, the time in therapeutic
range (TTR) of 2.0-3.0 was estimated. Additionally, the squared INR deviation was
investigated. To identify causes of INR-values below/above 2.0-3.0, a logistic regres-
sion on the basis of a TTR  60% as the dichotomous outcome was conducted.
RESULTS: For 525 patients from 71 study centers, at least two INR values were
available over a median observational period of 228.9 days (SD: 106.1 days). The
average TTR was 68.1 % (SD: 26.3 %). The average deviation of INR value from the
mean of the INR target range (2.5) was 0.44 (SD: 1.29). The results of themultivariate
regression (R20,179) show that themost important factors explaining a poor qual-
ity of anticoagulation therapy are bridging periods and patients self-reported need
of help regarding medication therapy without getting that help. In the group of
patients with a TTR60 %, the occurrence rate of clinical outcomes was higher
(p0.031) than in the group of patientswith a TTR60%.CONCLUSIONS: Labile INR
values lead to negative clinical outcomes. In order to improve the situation, the
main identified causes of poor anticoagulation quality should be addressed.
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OBJECTIVES: Atrial fibrillation (AF) has been identified by the Institute of Medicine
as one of the top research priorities for comparative effectiveness research, yet
there is limited methodological guidance on how to meet the evidentiary needs of
patients, clinicians, and payers. The Center for Medical Technology Policy (CMTP)
managed a stakeholder-driven process to develop an effectiveness guidance doc-
ument that issued guidance for trial designers on study design considerations to
best answer decision-makers’ needs in AF research. METHODS: The AF team re-
viewed the literature and conducted interviews with researchers, patients and
methodologists to scope the project needs. Open-question interviews were con-
ducted with 25 individuals from the clinical research, clinical practice, regulatory,
payer, professional organizations, and patient communities. An eight-person
multi-stakeholder technical working group worked in collaboration with CMTP
staff to establish and refine the recommendations. The methods recommenda-
tions were guided by the objective of achieving an acceptable balance across a
number of desirable dimensions, including internal validity, relevance, feasibility
and timeliness. The document was posted on CMTP’s website for a 30-day public
comment period as part of the broader dissemination and translation strategy.
RESULTS: The final recommendations provide guidance on the design of prospec-
tive studies in Atrial Fibrillation, rationale for their inclusion, specifics on imple-
mentation and data analysis/reporting considerations. The final list included five
research design recommendations, and three priority research areas that would
synergistically benefit stakeholders’ evidentiary needs and improve health
outcomes.CONCLUSIONS:Themeaningful engagement of patients, providers, and
decision makers to prioritize the questions and develop the methods to answer
A128 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 1 – A 2 5 6
